ATRA vs ETR · rev $128.9M vs P/E 28, rev $12.95B
Atara Biotherapeutics Inc (ATRA) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
ATRA currently screens at market cap $87.1M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the ATRA and ETR stock pages for the full models.
Not investment advice.